BioPharma Dive
MAY 31, 2025
AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its importance as a second-line treatment option.
pharmaphorum
MAY 31, 2025
Here, Liz Beatty co-founder and chief strategy officer of Inato speaks to the beginnings of a new era in drug development brought on by key technological advances in AI.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioPharma Dive
MAY 31, 2025
While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free survival was modest.
Pharmacy Times
MAY 31, 2025
IVIG treatment significantly boosts platelet counts in pregnant people with thrombocytopenia, revealing key predictors for effective response and optimizing clinical decisions.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
BioPharma Dive
MAY 31, 2025
The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe disease.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
MAY 31, 2025
The Food and Drug Administration approved Moderna’s new Covid-19 vaccine late Friday , though it placed restrictions on its use that the company’s existing Covid shot, Spikevax, does not currently face. The new vaccine, which will be marketed under the name mNexspike, will not immediately replace Spikevax. A statement from the company said both vaccines will be available on the market for the time being.
Pharmacy Times
MAY 31, 2025
Gurjyot K. Doshi, MD, discusses key updates to medically integrated pharmacy standards, which reflect the evolving landscape of oral oncolytic therapy.
STAT
MAY 31, 2025
CHICAGO — A treatment that combines two different types of cancer-fighting medicines — Gilead Sciences’ Trodelvy with Merck’s Keytruda — reduced the risk of tumor progression by more than one-third in women with an aggressive form of breast cancer. The results reported Saturday from the randomized Phase 3 study called ASCENT-04 could lead to a new treatment option for patients with newly diagnosed, metastatic, triple-negative breast cancer, experts said.
Pharmacy Times
MAY 31, 2025
Frank Qian, MD, MPH, discusses the clinical indications, dosing strategies, and cardiovascular outcomes data for prescription omega-3 fatty acids, including the ongoing debate about EPA vs EPA-DHA formulations and the implications of recent trial findings.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
MAY 31, 2025
This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter here. ASCO is usually sweltering, but it’s surprisingly chilly today. We’re back with a roundup of tragic paradoxes, a race for new breast cancer drugs, and all that jazz.
Pharmacy Times
MAY 31, 2025
At the 2025 National Lipid Association (NLA) Scientific Sessions, Marlys L. Koschinsky, PhD, FNLA, discusses the role of Lp(a) in cardiovascular risk and the emerging therapies designed to target and lower Lp(a) levels.
ID Stewardship
MAY 31, 2025
In this article an infectious diseases and antimicrobial stewardship pharmacist with 25+ years of experience in the pharmacy profession discusses five inconvenient truths to know about infectious diseases. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP with an introduction by ChatGPT AI-Generated Summary: This article outlines five fundamental truths about infectious diseases, emphasizing their complexity and the importance of vigilance.
Express Pharma
MAY 31, 2025
In 2024, the Indian government instituted new mandatory benchmarks for marketing practices applicable to pharmaceutical and medical device companies (involved in manufacturing, importing, selling and/or distribution) with the introduction of the Uniform Code for Pharmaceutical Marketing Practices, 2024 (UCPMP) and the Uniform Code for Marketing Practices in Medical Devices, 2024 (UCMPMD), respectively.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
MAY 31, 2025
CHICAGO — Amid ongoing uncertainty around funding for the National Institutes of Health, and what it could mean for U.S. innovation, a top Merck executive stressed that the agency is “an incredible super-highway for biomedicine,” and that it’s “a fragile thing.” The comments by Dean Li, Merck’s head of research and development, were made during a STAT event late Friday at the annual meeting of the American Society of Clinical Oncology, and ca
Expert insights. Personalized for you.
91 
Let's personalize your content